Daniel Cohen, Ph.D. is CEO and Co-founder of 3DBio Therapeutics (3DBio). 3DBio is a clinical-stage regenerative medicine company solving medical challenges by pioneering custom-engineered, patient-specific, 3D-bioprinted, living tissue implants. 3DBio’s groundbreaking approach develops living tissue implants with structural and functional integrity using a full suite of features to meet the FDA’s requirements for therapeutic manufacturing including novel and proprietary 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), specialized cell culture system, and implantable protective Overshell technology). 3DBio’s first investigational product, AuriNovo™, is currently being evaluated in a Phase 1/2a clinical trial for ear reconstruction in patients with microtia and has been granted Orphan Drug and Rare Pediatric Disease designation by the FDA. For more information visit: www.3dbiocorp.com

Created an offshoot of 3DBio Therapeutics at the start of the COVID-19 pandemic to provide healthcare workers with advanced personal protective equipment (PPE), specifically, Powered Air Purifying Respirators (PAPRs) that were made-in-USA and federally approved. PAPRs are electromechanical systems that provide a high level of respiratory protection with filtration of more than 99.97% of contaminant particles. American PAPR received multiple federal approvals from the Center for Disease Control / National Institute for Occupational Safety and Health (NIOSH).

• Predominantly worked with technology and industrial companies on projects addressing market entry, product launch, pricing, organizational transformation, post-merger management, procurement, and 3D printing innovation strategy• Extensively served private equity firms & hedge funds, including firm-level strategy, portfolio strategy, and due diligence• Conducted 25 projects in more than 15 industries, including medical devices, enterprise software, robotics, and aerospace• Affiliated with the Corporate Finance, Private Equity, and Manufacturing practices• Led several pro-bono strategy projects for New York City-based charities

Designed and prototyped homeland defense technology. Awarded patent based on this work.